Literature DB >> 9745858

Hepatic veno-occlusive disease in a case of polymyositis associated with thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.

Y Ishida1, M Utikoshi, M Kurosaki, K Ohta, T Chujo, S Aoyama, K Ohsawa, K Saito, H Yokoyama, S Ohta.   

Abstract

A 50-year-old woman was treated with prednisolone for polymyositis. During the therapy, thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) occurred. Neither plasma infusion nor plasma exchange could relieve the clinical manifestations of TTP/HUS. Moreover, massive ascites appeared and worsened her condition. She died approximately one year after the diagnosis of polymyositis. The autopsy revealed centri-lobular hepatic necrosis and nonthrombotic obliteration of hepatic small veins. The diagnosis of hepatic veno-occlusive disease (VOD) was made. It was suspected that common factors other than cytoreductive therapy had damaged the endothelium and caused TTP/HUS and VOD in a case of polymyositis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745858     DOI: 10.2169/internalmedicine.37.694

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.

Authors:  K P Ng; F Ramos; S M Sultan; D A Isenberg
Journal:  Clin Rheumatol       Date:  2009-04-23       Impact factor: 2.980

2.  Two difficulty diagnosis cases of severe veno-occlusive disease.

Authors:  Hisamitsu Miyaaki; Tatsuki Ichikawa; Naota Taura; Takuya Honda; Hidetaka Shibata; Taro Akashi; Shinobu Yamamichi; Shotaro Turuta; Akihiko Soyama; Masaaki Hidaka; Mitsuhisa Takatsuki; Sadayuki Okudaira; Susumu Eguchi; Osamu Nakashima; Masayoshi Kage; Kazuhiko Nakao
Journal:  Am J Case Rep       Date:  2013-03-29

3.  Thrombotic Microangiopathy with Polymyositis/Dermatomyositis: Three Case Reports and a Literature Review.

Authors:  Saeko Yamada; Hiroyuki Yamashita; Masahiro Nakano; Hiroaki Hatano; Toshiharu Sasaki; Yuko Takahashi; Hiroshi Kaneko
Journal:  Intern Med       Date:  2018-08-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.